TransHERA: The cell cycle regulator p27 predicts benefit from trastuzumab treatment in HER2-positive early breast cancer patients treated within the HERA trial
Date
2015-05-01ICR Author
Author
Filipits, M
Gnant, M
Dafni, U
Polydoropoulou, V
Hills, MJ
Leyland-Jones, B
Piccart-Gebhart, M
Dowsett, M
Type
Conference Proceeding
Metadata
Show full item recordCollections
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
Research team
Endocrinology
Language
eng
License start date
2015-05-01
Citation
CANCER RESEARCH, 2015, 75 pp. ? - ? (2)
Publisher
AMER ASSOC CANCER RESEARCH